Tokushima University / Educator and Researcher Directory --- Kataoka, Keiko

Personal Web Page

https://researchmap.jp/read0054329 (researchmap)

Field of Study

○	Medicine

Subject of Study

○

Book / Paper

Book:

1.	Keiko Kataoka : Integrative Advances in Rice Research, --- Chapter 13: Fermented Brown Rice as a Functional Food ---, IntechOpen, Jul. 2021. (Link to Publication Site) ● Publication site (DOI): 10.5772/intechopen.98840 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.5772/intechopen.98840 (DOI: 10.5772/intechopen.98840)
2.	Keiko Kataoka and Kazumi Ozaki : 太田敏子岡崎充宏金森政人古畑勝則松村充山本容正 (編集): メデイカルサイエンス微生物検査学第2版, 近代出版, Tokyo, Nov. 2016.
3.	Keiko Kataoka : 太田敏子岡崎充宏金森政人古畑勝則松村充山本容正 (編集): メデイカルサイエンス微生物検査学第2版, 近代出版, Tokyo, Nov. 2016.
4.	Keiko Kataoka : 遺伝子検査技術ー遺伝子分析科学認定士テキストー改訂第2版, 宇宙堂八木書店, Tokyo, Jan. 2016.

Academic Paper (Judged Full Paper):

1.	Seryoung Kim, Satomi Masai, Keiji Murakami, Momoyo Azuma, Keiko Kataoka, Mayu Sebe, Kazuya Shimizu, Tomoaki Itayama, Niwooti Whangchai, Kanda Whangchai, Ikko Ihara and Hideaki Maseda : Characteristics of Antibiotic Resistance and Tolerance of Environmentally Endemic ., Antibiotics, Vol.11, No.8, 1120, 2022. (Summary) Antibiotic-resistant bacteria remain a serious public health threat. In order to determine the percentage of antibiotic-resistant and -tolerant cells present and to provide a more detailed infection risk of bacteria present in the environment, an isolation method using a combination of 41 °C culture and specific primers was established to evaluate in the environment. The 50 strains were randomly selected among 110 isolated from the river. The results of antibiotic susceptibility evaluation showed that only 4% of environmental strains were classified as antibiotic-resistant, while 35.7% of clinical strains isolated in the same area were antibiotic-resistant, indicating a clear difference between environmental and clinical strains. However, the percentage of antibiotic-tolerance, an indicator of potential resistance risk for strains that have not become resistant, was 78.8% for clinical strains and 90% for environmental strains, suggesting that , a known cause of nosocomial infections, has a high rate of antibiotic-tolerance even in environmentally derived strains. It suggested that the rate of antibiotic-tolerance is not elicited by the presence or absence of antimicrobial exposure. The combination of established isolation and risk analysis methods presented in this study should provide accurate and efficient information on the risk level of in various regions and samples. (Link to Publication Site) ● Publication site (DOI): 10.3390/antibiotics11081120 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 36009989 ● Summary page in Scopus @ Elsevier: 2-s2.0-85137360864 (DOI: 10.3390/antibiotics11081120, PubMed: 36009989, Elsevier: Scopus)
2.	Mizuki Abe, Keiji Murakami, Yuka Hiroshima, Takashi Amoh, Mayu Sebe, Keiko Kataoka and Hideki Fujii : Autoinducer Analogs Can Provide Bactericidal Activity to Macrolides in Pseudomonas aeruginosa through Antibiotic Tolerance Reduction, Antibiotics, Vol.11, No.1, 2021. (Summary) Macrolide antibiotics are used in treating chronic biofilm infections despite their unsatisfactory antibacterial activity, because they display several special activities, such as modulation of the bacterial quorum sensing and immunomodulatory effects on the host. In this study, we investigated the effects of the newly synthesized quorum-sensing autoinducer analogs (AIA-1, -2) on the activity of azithromycin and clarithromycin against . In the killing assay of planktonic cells, AIA-1 and -2 enhanced the bactericidal ability of macrolides against PAO1; however, they did not affect the minimum inhibitory concentrations of macrolides. In addition, AIA-1 and -2 considerably improved the killing activity of azithromycin and clarithromycin in biofilm cells. The results indicated that AIA-1 and -2 could affect antibiotic tolerance. Moreover, the results of hydrocarbon adherence and cell membrane permeability assays suggested that AIA-1 and -2 changed bacterial cell surface hydrophobicity and accelerated the outer membrane permeability of the hydrophobic antibiotics such as azithromycin and clarithromycin. Our study demonstrated that the new combination therapy of macrolides and AIA-1 and -2 may improve the therapeutic efficacy of macrolides in the treatment of chronic biofilm infections. (Tokushima University Institutional Repository) ● Metadata: 117210 (Link to Publication Site) ● Publication site (DOI): 10.3390/antibiotics11010010 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35052885 ● Summary page in Scopus @ Elsevier: 2-s2.0-85121669540 (Tokushima University Institutional Repository: 117210, DOI: 10.3390/antibiotics11010010, PubMed: 35052885, Elsevier: Scopus)
3.	Keiko Kataoka, Hideyuki Nemmoto, Akiko Sakurai, Koji Yasutomo and Masataka Shikanai : Preventive effect of fermented brown rice and rice bran on spontaneous type 1 diabetes in NOD female mice, Journal of Functional Foods, Vol.78, 104356, 2021. (Tokushima University Institutional Repository) ● Metadata: 116549 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jff.2021.104356 (Link to Search Site for Scientific Articles) ● Summary page in Scopus @ Elsevier: 2-s2.0-85099455517 (Tokushima University Institutional Repository: 116549, DOI: 10.1016/j.jff.2021.104356, Elsevier: Scopus)
4.	Momoyo Azuma, Keiji Murakami, Rina Murata, Keiko Kataoka, Hideki Fujii, Yoichiro Miyake and Yasuhiko Nishioka : Clinical Significance of Carbapenem-Tolerant Pseudomonas aeruginosa Isolated in the Respiratory Tract, Antibiotics, Vol.9, No.9, 2020. (Summary) infections. (Tokushima University Institutional Repository) ● Metadata: 116480 (Link to Publication Site) ● Publication site (DOI): 10.3390/antibiotics9090626 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 32967210 ● Search Scopus @ Elsevier (PMID): 32967210 ● Search Scopus @ Elsevier (DOI): 10.3390/antibiotics9090626 (Tokushima University Institutional Repository: 116480, DOI: 10.3390/antibiotics9090626, PubMed: 32967210)
5.	Ahmed Zaied Bhuyan, Hideki Arimochi, Jun Nishida, Keiko Kataoka, Takeshi Kurihara, Chieko Ishifune, Hideki Tsumura, Morihiro Ito, Yasuhiko Ito, Akiko Kitamura and Koji Yasutomo : CD98hc regulates the development of experimental colitis by controlling effector and regulatory CD4(+) T cells., Biochemical and Biophysical Research Communications, Vol.444, No.4, 628-633, 2014. (Summary) CD4(+) T cell activation is controlled by signaling through the T cell receptor in addition to various co-receptors, and is also affected by their interactions with effector and regulatory T cells in the microenvironment. Inflammatory bowel diseases (IBD) are caused by the persistent activation and expansion of auto-aggressive CD4(+) T cells that attack intestinal epithelial cells. However, the molecular basis for the persistent activation of CD4(+) T cells in IBD remains unclear. In this study, we investigated how the CD98 heavy chain (CD98hc, Slc3a2) affected the development of colitis in an experimental animal model. Transferring CD98hc-deficient CD4(+)CD25(-) T cells into Rag2(-/-) mice did not cause colitis accompanied by increasing Foxp3(+) inducible regulatory T cells. By comparison, CD98hc-deficient naturally occurring regulatory T cells (nTregs) had a decreased capability to suppress colitis induced by CD4(+)CD25(-) T cells, although CD98hc-deficient mice did not have a defect in the development of nTregs. Blocking CD98hc with an anti-CD98 blocking antibody prevented the development of colitis. Our results indicate that CD98hc regulates the expansion of autoimmune CD4(+) T cells in addition to controlling nTregs functions, which suggests the CD98hc as an important target molecule for establishing strategies for treating colitis. (Keyword) Animals / Antigens, CD98 Heavy Chain / Autoimmune Diseases / CD4-Positive T-Lymphocytes / Colitis / Colon / DNA-Binding Proteins / Gene Deletion / Interleukin-2 Receptor alpha Subunit / Mice / Mice, Inbred BALB C / Mice, Inbred C57BL (Link to Publication Site) ● Publication site (DOI): 10.1016/j.bbrc.2014.01.144 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 24491544 ● Summary page in Scopus @ Elsevier: 2-s2.0-84894522828 (DOI: 10.1016/j.bbrc.2014.01.144, PubMed: 24491544, Elsevier: Scopus)
6.	Kohhei Nakajima, Yoichi Maekawa, Keiko Kataoka, Chieko Ishifune, Jun Nishida, Hideki Arimochi, Akiko Kitamura, Takayuki Yoshimoto, Shuhei Tomita, Shinji Nagahiro and Koji Yasutomo : The ARNT-STAT3 axis regulates the differentiation of intestinal intraepithelial TCRαβ⁺CD8αα⁺cells., Nature Communications, Vol.4, 2112, 2013. (Summary) Intestinal intraepithelial T cells contribute to the regulation of inflammatory responses in the intestine; however, the molecular basis for their development and maintenance is unknown. The aryl hydrocarbon receptor complexes with the aryl hydrocarbon receptor nuclear translocator (ARNT) and senses environmental factors, including gut microbiota. Here, we identify ARNT as a critical regulator of the differentiation of TCRαβ(+)CD8αα(+) intestinal intraepithelial T cells. Mice deficient in either ARNT or aryl hydrocarbon receptor show a greater than- eight-fold reduction in the number of TCRαβ(+)CD8αα(+) intestinal intraepithelial T cells. The number of TCRαβ(+)CD8αα(+) intestinal intraepithelial T cells is increased by treatment with an aryl hydrocarbon receptor agonist in germ-free mice and is decreased by antibiotic treatment. The Arnt-deficient precursors of TCRαβ(+)CD8αα(+) intestinal intraepithelial T cells express low amounts of STAT3 and fail to differentiate towards the TCRαβ(+)CD8αα(+) cell fate after IL-15 stimulation, a deficiency that is overcome by overexpression of Stat3. These data demonstrate that the ARNT-STAT3 axis is a critical regulator of TCRαβ(+)CD8αα(+) intestinal intraepithelial T-cell development and differentiation. (Keyword) Animals / Antigens, CD8 / Aryl Hydrocarbon Receptor Nuclear Translocator / CD8-Positive T-Lymphocytes / Cell Differentiation / Cells, Cultured / Female / Gene Expression Regulation / Interleukin-15 / Intestinal Mucosa / Intestines / Mice / Mice, Inbred C57BL / Mice, Transgenic / Precursor Cells, T-Lymphoid / Receptors, Antigen, T-Cell, alpha-beta / STAT3 Transcription Factor / Signal Transduction / beta-Naphthoflavone (Tokushima University Institutional Repository) ● Metadata: 105939 (Link to Publication Site) ● Publication site (DOI): 10.1038/ncomms3112 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23836150 ● Summary page in Scopus @ Elsevier: 2-s2.0-84880260699 (Tokushima University Institutional Repository: 105939, DOI: 10.1038/ncomms3112, PubMed: 23836150, Elsevier: Scopus)
7.	Hideyuki Nemoto, Keiko Kataoka, Hideki Ishikawa, Kazue Ikata and Hideki Arimochi : Reduced Diversity and Imbalance of Fecal Microbiota in Patients with Ulcerative Colitis, Digestive Diseases and Sciences, Vol.57, No.11, 2955-2964, 2012. (Summary) Clinical observations and experimental colitis models have indicated the importance of intestinal bacteria in the etiology of ulcerative colitis (UC), but a causative bacterial agent has not been identified. To determine how intestinal bacteria are associated with UC, fecal microbiota and other components were compared for UC patients and healthy adults. Fresh feces were collected from 48 UC patients. Fecal microbiota were analyzed by use of terminal-restriction fragment length polymorphism (T-RFLP), real-time PCR, and culture. The concentrations of organic acids, indole, and ammonia, and pH and moisture, which are indicators of the intestinal environment, were measured and compared with healthy control data. T-RFLP data divided the UC patients into four clusters; one cluster was obtained for healthy subjects. The diversity of fecal microbiota was significantly lower in UC patients. There were significantly fewer Bacteroides and Clostridium subcluster XIVab, and the amount of Enterococcus was higher in UC patients than in healthy subjects. The fecal concentration of organic acids was significantly lower in UC patients who were in remission. UC patients have imbalances in the intestinal environment-less diversity of fecal microbiota, lower levels of major anaerobic bacteria (Bacteroides and Clostridium subcluster XIVab), and a lower concentration of organic acids. (Keyword) Adult / Aged / Bacteria / Case-Control Studies / Colitis, Ulcerative / DNA, Bacterial / Feces / Female / Humans / Intestinal Mucosa / Male / Middle Aged / Polymorphism, Restriction Fragment Length / Real-Time Polymerase Chain Reaction / Statistics, Nonparametric (Link to Publication Site) ● Publication site (DOI): 10.1007/s10620-012-2236-y (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22623042 ● Summary page in Scopus @ Elsevier: 2-s2.0-84871530893 (DOI: 10.1007/s10620-012-2236-y, PubMed: 22623042, Elsevier: Scopus)
8.	Shuichi Iwahashi, Yoichi Maekawa, Jun Nishida, Chieko Ishifune, Akiko Kitamura, Hideki Arimochi, Keiko Kataoka, Shigeru Chiba, Mitsuo Shimada and Koji Yasutomo : Notch2 regulates the development of marginal zone B cells through Fos., Biochemical and Biophysical Research Communications, Vol.418, No.4, 701-707, 2012. (Summary) B cells are classified into several subsets depending on their functions, marker expression pattern and localization. Marginal zone B (MZB) cells are a distinct lineage from follicular B cells, and regulate host defenses against blood-borne pathogens. Notch2/RBP-J signaling regulates the development of MZB cells by interacting with delta-like 1 ligand, although the target genes for Notch2 signaling remain unclear. We identified Fos as an upregulated gene in LPS-stimulated B cells that received Notch2 signaling. Fos is expressed in CD21(high)CD23(low) MZB cells at a higher level compared to CD21(Int)CD23(high) follicular B cells. Deleting the Notch2 gene in CD19(+) B cells decreased Fos expression in B cells. Overexpression of Fos in Notch2-deficient B cells or bone marrow cells partially restored MZB development. Fos promoter activity was upregulated by Notch2 signaling, indicating that Notch2 directly controls Fos transcription associated with MZB development. These data identify Fos as one of the target genes for Notch2 signaling that is crucial for MZB development. (Keyword) Animals / B-Lymphocytes / Gene Expression Regulation, Developmental / Genes, Reporter / Luciferases / Mice / Mice, Inbred C57BL / Oncogene Proteins v-fos / Promoter Regions, Genetic / Receptor, Notch2 / Spleen / Transcription, Genetic (Link to Publication Site) ● Publication site (DOI): 10.1016/j.bbrc.2012.01.082 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22293205 ● Summary page in Scopus @ Elsevier: 2-s2.0-84857441564 (DOI: 10.1016/j.bbrc.2012.01.082, PubMed: 22293205, Elsevier: Scopus)
9.	Hideki Arimochi, Kyoji Morita, Nakanishi Shusuke, Keiko Kataoka and Tomomi Kuwahara : Production of apoptosis-inducing substances from soybean protein by Clostridium butyricum: Characterization of their toxic effects on human colon carcinoma cells, Cancer Letters, Vol.277, No.2, 190-198, 2009. (Summary) Microbial metabolism of soybean constituents is known to produce novel active substances as a chemopreventive agent during the fermentation, and enterobacteria are expected to produce chemopreventive agents as a consequence of metabolizing soybean constituents in the intestinal tract. Then, the conditioned medium was prepared by culturing an enterobacterium Clostridium butyricum (C. butyricum) with soybean protein, and its direct effect on human colon carcinoma HCT116 cells was examined. The conditioned medium was shown to induce the cell death, and suggested to contain novel apoptosis-inducing substances. Thus, enterobacteria are predicted to produce anti-tumor substances from food-derived proteins within the intestinal tract. (Keyword) Antineoplastic Agents, Phytogenic / Apoptosis / Cell Survival / Clostridium butyricum / Colonic Neoplasms / Culture Media, Conditioned / HCT116 Cells / Humans / Soybean Proteins (Link to Publication Site) ● Publication site (DOI): 10.1016/j.canlet.2008.12.006 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 19147278 ● Search Scopus @ Elsevier (PMID): 19147278 ● Search Scopus @ Elsevier (DOI): 10.1016/j.canlet.2008.12.006 (DOI: 10.1016/j.canlet.2008.12.006, PubMed: 19147278)
10.	Keiko Kataoka, Sachiko Ogasa, Tomomi Kuwahara, Yoshimi Bando, Mari Hagiwara, Hideki Arimochi, Shuusuke Nakanishi, Teruaki Iwasaki and Yoshinari Ohnishi : Inhibitory effects of fermented brown rice on induction of acute colitis by dextran sulfate sodium in rats., Digestive Diseases and Sciences, Vol.53, No.6, 1601-1608, 2008. (Summary) Although the pathogenic mechanisms of inflammatory bowel diseases are not fully understood, colonic microbiota may affect the induction of colonic inflammation, and some probiotics and prebiotics have been reported to suppress colitis. The inhibitory effects of brown rice fermented by Aspergillus oryzae (FBRA), a fiber-rich food, on the induction of acute colitis by dextran sulfate sodium (DSS) were examined. Feeding a 5% and 10% FBRA-containing diet significantly decreased the ulcer and erosion area in the rat colon stained with Alcian blue. In another experiment, 10% FBRA feeding decreased the ulcer index (percentage of the total length of ulcers in the full length of the colon) and colitis score, which were determined by macroscopic observation. It also decreased myeloperoxidase activity in the colonic mucosa. Viable cell numbers of Lactobacillus in the feces decreased after DSS administration and was reversely correlated with severity of colitis, while the cell number of Enterobacteriaceae increased after DSS treatment and was positively correlated with colitis severity. These results indicate that FBRA has a suppressive effect on the induction of colitis by DSS and suggest FBRA-mediated modification of colonic microbiota. (Keyword) Acute Disease / Animals / Aspergillus oryzae / Chi-Square Distribution / Colitis / Colon / Dextran Sulfate / Fermentation / Nutritional Physiological Phenomena / Oryza sativa / Peroxidase / Rats / Rats, Wistar / Statistics, Nonparametric (Link to Publication Site) ● Publication site (DOI): 10.1007/s10620-007-0063-3 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 17957470 ● Search Scopus @ Elsevier (PMID): 17957470 ● Search Scopus @ Elsevier (DOI): 10.1007/s10620-007-0063-3 (DOI: 10.1007/s10620-007-0063-3, PubMed: 17957470)
11.	Keiko Kataoka, Kibe Ryoko, Tomomi Kuwahara, Hagiwara Mari and Hideki Arimochi : Modifying effects of fermented brown rice on fecal microbiota in rats, Anaerobe, Vol.13, No.5-6, 220-227, 2007. (Summary) Brown rice fermented by Aspergillus oryzae (FBRA) is a fiber-rich food. Effects of dietary administration of FBRA on rat fecal microbiota composition were examined. Male Wistar rats were fed a basal diet or a 5% FBRA- or 10% FBRA-containing diet, and fecal microbiota was analyzed by culture and terminal-restriction fragment length polymorphism (T-RFLP) analysis. The viable cell number of lactobacilli significantly increased after feeding 10% FBRA diet for 3 weeks compared with that in the basal diet group and that in the same group at the beginning of the experiment (day 0). An increase in the viable cell number of lactobacilli was also observed after feeding 10% FBRA for 12 weeks compared with the effect of a basal diet. T-RFLP analysis showed an increase in the percentage of lactobacilli cells in feces of rats fed 10% FBRA for 14 weeks. Lactobacilli strains isolated from rat feces were divided into six types based on their randomly amplified polymorphic DNA (RAPD) patterns, and they were identified as Lactobacillus reuteri, L. intestinalis and lactobacilli species based on homology of the partial sequence of 16S rDNA. FBRA contains lactic acid bacteria, but their RAPD patterns and identified species were different from those in rat feces. These results indicated that dietary FBRA increases the number of lactobacilli species already resident in the rat intestine. (Keyword) Animals / Aspergillus oryzae / Colon / Dietary Fiber / Feces / Fermentation / Lactobacillus / Male / Nutritional Physiological Phenomena / Oryza / Polymorphism, Restriction Fragment Length / RNA, Ribosomal, 16S / Random Amplified Polymorphic DNA Technique / Rats / Rats, Wistar (Link to Publication Site) ● Publication site (DOI): 10.1016/j.anaerobe.2007.07.001 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 17826198 ● Summary page in Scopus @ Elsevier: 2-s2.0-36049010342 (DOI: 10.1016/j.anaerobe.2007.07.001, PubMed: 17826198, Elsevier: Scopus)
12.	Hideki Arimochi, Kyoji Morita, Keiko Kataoka, Shusuke Nakanishi, Tomomi Kuwahara and Yoshinari Ohnishi : Suppressive effect of Clostridium perfringens-produced heat-stable substance(s) on proliferation of human colon adenocarcinoma HT29 cells in culture, Cancer Letters, Vol.241, No.2, 228-234, 2006. (Summary) Clostridium perfringens has been regarded as one of the intestinal bacteria increasing colon cancer risk. In previous studies, we have shown that the oral administration of C. perfringens culture medium can inhibit the mutagen-induced formation of pre-neoplastic lesions in rat colon, thus proposing the existence of factor(s) preventing colon tumorigenesis in this culture medium. However, the properties of effective factor(s) and the mechanism of this inhibitory action still remain to be investigated. Then, the effect of C. perfringens culture medium on human colon adenocarcinoma HT29 cells was examined. The exposure of HT29 cells to C. perfringens culture medium was found to suppress the proliferation of these cells probably through the reduction of immediate early gene egr-1 expression. These observations suggest that C. perfringens culture medium has a cytostatic action on colon tumor cells, which may be responsible for the prevention of pre-neoplastic formation in rat colon. (Keyword) Adenocarcinoma / Cell Proliferation / Clostridium Infections / Clostridium perfringens / Colonic Neoplasms / Culture Media / Early Growth Response Protein 1 / HT29 Cells / Hot Temperature / Humans / Immunoblotting / Reverse Transcriptase Polymerase Chain Reaction / T lymphocytes (Link to Publication Site) ● Publication site (DOI): 10.1016/j.canlet.2005.10.016 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 16300879 ● Summary page in Scopus @ Elsevier: 2-s2.0-33746736840 (DOI: 10.1016/j.canlet.2005.10.016, PubMed: 16300879, Elsevier: Scopus)
13.	Mari Hagiwara, Keiko Kataoka, Hideki Arimochi, Tomomi Kuwahara, Haruyuki Nakayama and Yoshinari Ohnishi : Inhibitory effect of fluvastatin on ileal ulcer formation in rats induced by nonsteroidal antiinflammatory drug, World Journal of Gastroenterology : WJG, Vol.11, No.7, 1040-1043, 2005. (Summary) Nonsteroidal anti-inflammatory drugs (NSAIDs) cause gastrointestinal damage as one of their side effects in humans and experimental animals. Lipid peroxidation plays an important role in NSAID-induced ulceration. The aim of this study was to investigate the inhibitory effect of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors on the ulceration in small intestines of rats. The effects of three HMG-CoA reductase inhibitors, fluvastatin, pravastatin and atorvastatin on ileal ulcer formation in 5-bromo-2-(4-fluorophenyl)-3-(4- methylsulfonylphenyl) thiophene (BFMeT)-treated rats were examined. Antioxidative activity of the inhibitors was measured by a redox-linked colorimetric method. Fluvastatin, which was reported to have antioxidative activity, repressed the ileal ulcer formation in rats treated with BFMeT an NSAIDs. However, the other HMG-CoA reductase inhibitors (pravastatin and atorvastatin) did not repress the ileal ulcer formation. Among these HMG-CoA reductase inhibitors, fluvastatin showed a significantly stronger reducing power than the others (pravastatin, atorvastatin). Fluvastatin having the antioxidaitive activity suppresses ulcer formation in rats induced by NSAIDs. (Keyword) ileal ulcer / fluvastatin / HMG-CoA reductase inhibitors / nonsteroidal antiinflammatory drug (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 15742411 ● Search Scopus @ Elsevier (PMID): 15742411 (PubMed: 15742411)
14.	Tsuyoshi Miki, Tomomi Kuwahara, Haruyuki Nakayama, Natsumi Okada, Keiko Kataoka, Hideki Arimochi and Yoshinari Ohnishi : Simultaneous detection of Bacteroides fragilis group species by leuB-directed PCR, The Journal of Medical Investigation : JMI, Vol.52, No.1,2, 101-108, 2005. (Summary) Bacteroides species, saccharolytic Gram-negative obligate anaerobes, are frequently isolated from human infections such as peritonitis, abscesses and bacteremia. Among the species in the genus Bacteroides, the species called "B. fragilis group" are particularly involved in human infections and are medically important because they account for a major part of anaerobic isolates from clinical specimens. The purpose of this study was to develop PCR primers that specifically and simultaneously amplify the beta -isopropylmalate dehydrogenase gene leuB in B. fragilis group species. We determined partial nucleotide sequences of leuB genes and compared them in seventeen strains of nine B. fragilis group species, and the regions that are conserved among Bacteroides strains but different from other species were used as a B. fragilis group-specific PCR primer set, BacLBF-BacLBR. Specificity tests of the primer set using 52 phenotypically characterized strains and 75 isolates from rat feces showed only one case each of false-positive and false-negative. The detection limit of the leuB-directed PCR using BacLBF and BacLBR was 3.9 x 10(3) colony-forming units. These results indicate that leuB amplification using BacLBF andBacLBR is a useful tool for rapid diagnosis of Bacteriodes infection and for rapid differential diagnosis of anaerobic infections. (Keyword) Bacteroides / leuB / PCR / rapid detection (Tokushima University Institutional Repository) ● Metadata: 110763 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.52.101 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 15751280 ● Search Scopus @ Elsevier (PMID): 15751280 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.52.101 (Tokushima University Institutional Repository: 110763, DOI: 10.2152/jmi.52.101, PubMed: 15751280)
15.	Piyawan Bunpo, Keiko Kataoka, Hideki Arimochi, Haruyuki Nakayama, Tomomi Kuwahara, Usanee Vinitketkumnuen and Yoshinari Ohnishi : Inhibitory effects of asiatic acid and CPT-11 on growth of HT-29 cells, The Journal of Medical Investigation : JMI, Vol.52, No.1,2, 65-73, 2005. (Keyword) asiatic acid / apoptosis / CPT-11 / combination / cytotoxicity (Tokushima University Institutional Repository) ● Metadata: 110758 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.52.65 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 15751275 ● CiNii @ National Institute of Informatics (CRID): 1390282679221384192 ● Search Scopus @ Elsevier (PMID): 15751275 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.52.65 (Tokushima University Institutional Repository: 110758, DOI: 10.2152/jmi.52.65, PubMed: 15751275, CiNii: 1390282679221384192)
16.	Piyawan Bunpo, Keiko Kataoka, Hideki Arimochi, Haruyuki Nakayama, Tomomi Kuwahara, Yoshimi Bando, Keisuke Izumi, Usanee Vinitketkumnuen and Yoshinari Ohnishi : Inhibitory effects of Centella asiatica on azoxymethane-induced aberrant crypt focus formation and carcinogenesis in the intestines of F344 rats, Food and Chemical Toxicology, Vol.42, No.12, 1987-1997, 2004. (Summary) Effects of the water extract of Centella asiatica Linn. on formation of azoxymethane (AOM)-induced aberrant crypt foci (ACF) and intestinal tumorigenesis in male F344 rats were investigated. Treatment with the extract significantly decreased the number of larger ACF (with four or more crypts per focus) in the large intestine in the early stage, while the number of methylated DNA adducts was not decreased compared with that in the AOM-treated group. In the post-initiation stage, the extract significantly decreased the total number of ACF and the number of larger ACF, accompanied by a decrease in the 5-bromo-2'-deoxyuridine-labeling index and an increase in the induction of apoptotic cells in the colonic mucosa. The incidences of neoplasms, the numbers of adenocarcinomas in the small intestines and entire intestines, and sizes of neoplasms in the entire intestines in rats fed C. asiatica extract at a dose of 10 mg/kg were smaller than those in rats given AOM alone (p < 0.05). The extract at a dose of 100 mg/kg significantly reduced the multiplicity of neoplasms in the small intestine (p < 0.05). These results suggest that inhibition of the formation of AOM-induced ACF by C. asiatica extract is associated with modification of cell proliferation and induction of apoptosis in colonic crypts and that the extract has a chemopreventive effect on colon tumorigenesis. (Keyword) Azoxymethane (AOM) / Aberrant crypt foci (ACF) / Intestinal tumor / Centella asiatica / Cell proliferation / apoptosis (Link to Publication Site) ● Publication site (DOI): 10.1016/j.fct.2004.06.022 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 15500935 ● Search Scopus @ Elsevier (PMID): 15500935 ● Search Scopus @ Elsevier (DOI): 10.1016/j.fct.2004.06.022 (DOI: 10.1016/j.fct.2004.06.022, PubMed: 15500935)
17.	Naruhiko Sawada, Keiko Kataoka, Kazuya Kondo, Hideki Arimochi, H Fujino, Y Takahashi, Takanori Miyoshi, Tomomi Kuwahara, Y Monden and Yoshinari Ohnishi : Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice, British Journal of Cancer, Vol.90, No.8, 1672-1678, 2004. (Summary) We examined the antitumour effect of a combination of betulinic acid (BA) and vincristine (VCR) on murine melanoma B16F10 cells in vitro and in vivo. Betulinic acid, a pentacyclic triterpene, showed a synergistic cytotoxic effect on melanoma cells by combinational use of VCR. Betulinic acid and VCR induced cell cycle arrest at different points (BA at G1 phase and VCR at G2/M phase) and caused apoptosis in B16F10 melanoma cells. In the in vivo study, VCR inhibited metastasis of tumour cells to the lung. The addition of BA to VCR augmented suppression of the experimental lung metastasis of melanoma cells in C57BL/6 mice. The number of lung nodules of more than 1 mm in diameter in mice treated with BA and VCR was less than that in mice treated with VCR alone. These results suggest that BA is an effective supplement for enhancing the chemotherapeutic effect on malignant melanoma. (Keyword) synergistic antitumour effect / betulinic acid / vincristine / cell cycle arrest / G1 phase (Link to Publication Site) ● Publication site (DOI): 10.1038/sj.bjc.6601746 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 15083202 ● Search Scopus @ Elsevier (PMID): 15083202 ● Search Scopus @ Elsevier (DOI): 10.1038/sj.bjc.6601746 (DOI: 10.1038/sj.bjc.6601746, PubMed: 15083202)
18.	Mari Hagiwara, Keiko Kataoka, Hideki Arimochi, Tomomi Kuwahara and Yoshinari Ohnishi : Role of unbalanced growth of Gram-negative bacteria in ileal ulcer formation in rats treated with a nonsteroidal anti-inflammatory drug, The Journal of Medical Investigation : JMI, Vol.51, No.1,2, 43-51, 2004. (Summary) Nonsteroidal anti-inflammatory drugs (NSAIDs) induced formation of intestinal ulcers as side effects, in which an unbalanced increase in the number of gram-negative bacteria in the small intestine plays an important role. To clarify how intestinal microflora are influenced by NSAIDs, we examined the effects of 5-bromo-2-(4-fluorophenyl)-3-(4-methylsulfonylphenyl) thiophene (BFMeT), an NSAID, on intestinal motility and on the growth of Escherichia coli and Lactobacillus acidophilus. Transit index, a marker of peristalsis, was not different in BFMeT-treated and solvent-treated rats, indicating that BFMeT increased the number of gram-negative bacteria without suppression of peristalsis. The factors that affect the growth of intestinal bacteria were not found in intestinal contents of BFMeT-treated rats, because the growth of E. coli and that of L. acidophilus in the supernatants of small intestinal contents of BFMeT-treated rats and solvent-treated rats were not different. The mechanism of the increase in the number of gram-negative bacteria is still unclear, but heat-killed E. coli cells and their purified lipopolysaccharide (LPS) caused deterioration of BFMeT-induced ileal ulcers, while they could not cause the ulcers by themselves without the NSAID. Concentration of LPS and myeloperoxidase activity level were elevated correlatively in the intestinal mucosa of rats treated with LPS and BFMeT. These results suggest that an increase in the number of gram-negative bacteria and their LPS in the mucosa induces activation of neutrophils together with the help of NSAID action and causes ulcer formation. (Keyword) nonsteroidal anti-inflammatory drugs (NSAIDs) / ulcer formation / lipopolysaccharide (LPS) / Escherichia coli / myeloperoxidase (MPO) (Tokushima University Institutional Repository) ● Metadata: 110713 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.51.43 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 15000255 ● Search Scopus @ Elsevier (PMID): 15000255 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.51.43 (Tokushima University Institutional Repository: 110713, DOI: 10.2152/jmi.51.43, PubMed: 15000255)
19.	Shuusuke Nakanishi, Keiko Kataoka, Tomomi Kuwahara and Yoshinari Ohnishi : Effects of high amylose maize starch and Clostridium butyricum on metabolism in colonic microbiota and formation of azoxymethane-induced aberrant crypt foci in the rat colon, Microbiology and Immunology, Vol.47, No.12, 951-958, 2003. (Summary) High amylose maize starch (HAS) is not digested in the small intestine and most of it reaches the large intestine. In the large intestine, HAS is fermented by intestinal bacteria, resulting in production of short-chain fatty acids (SCFA), particularly butyrate. Clostridium butyricum can utilize HAS and produce butyrate and acetate. It has been proposed that butyrate inhibits carcinogenesis in the colon. In this study, we examined the inhibitory effects of HAS and C. butyricum strain MIYAIRI588 (CBM588) on azoxymethane-induced aberrant crypt foci (ACF) formation in rats. In the group of rats administered only CBM588 spores, the concentration of butyrate in the cecum increased, but there was no decrease in the number of ACF. In the group of rats fed an HAS diet, a decrease in the number of ACF was observed, and in the group of rats administered HAS and CBM588, the number of ACF decreased significantly. In these two groups, the concentrations of acetate and propionate in intestinal contents significantly increased, but the concentration of butyrate did not change. It was found that the beta-glucuronidase activity level of colonic contents decreased significantly in the two groups of rats fed HAS. This study showed that HAS and CBM588 changed the metabolism of colonic microbiota and decreased the level of beta-glucuronidase activity, phenomena that may play a role in the inhibition of ACF formation in the rat colon. (Keyword) Clostridium butyricum / High amylose starch / Azoxymethane / Aberrant crypt foci (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 14695445 ● Search Scopus @ Elsevier (PMID): 14695445 (PubMed: 14695445)
20.	Yaowarate Intiyot, Takemi Kinouchi, Keiko Kataoka, Hideki Arimochi, Tomomi Kuwahara, Usanee Vinitketkumnuen and Yoshinari Ohnishi : Antimutagenicity of Murdannia loriformis in the Salmonella mutation assay and its inhibitory effects on azoxymethane-induced DNA methylation and aberrant crypt focus formation in male F344 rats, The Journal of Medical Investigation : JMI, Vol.49, No.1,2, 25-34, 2002. (Summary) An 80% ethanol extract of Murdannia loriformis, a Thai medicinal plant, was examined for antimutagenic activity and cancer chemopreventive activity. In the Salmonella mutation assay, the extract showed antimutagenicity against 2-amino-3-methylimidazo [4,5-f]quinoline, 2-amino-3,4-dimethylimidazo[4,5-f]quinoline, 2-amino-3,8-dimethylimidazo [4,5-f]quinoxaline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, 2-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole, 3-amino-1-methyl-5H-pyrido[4,3-b]indole, 2-amino-6-methyldipyrido [1,2-a:3',2'-d] imidazole, 2-aminodipyrido[1,2-a:3',2'-d]imidazole, 2-aminoanthracene, 2-(2-furyl)-3-(5-nitro-2-furyl) acrylamide, N-methyl-N'-nitro-N-nitrosoguanidine and methylazoxymethanol acetate and reduced their mutagenicities to 31.4-67.9% at the dose of 10 mg/plate. However, it did not inhibit the mutagenicities of 2-amino-9H-pyrido[2,3-b]indole, 2-amino-3-methyl-9 H-pyrido[2,3-b]indole, benzo[a]pyrene,N-ethyl-N'-nitro-N-nitrosoguanidine and 1-nitropyrene. The extract itself showed no mutagenicity. The chemopreventive activity of M. loriformis was examined using azoxymethane (AOM)-induced aberrant crypt focus (ACF) formation in the colon of F344 rats. The extract at doses of 0.1-1.0 g/kg wt significantly inhibited ACF formation in the initiation stage (21-51%), although it was more effective at a lower dose. In the post-initiation stage, the extract also tended to inhibit ACF formation (12-27%) and significantly decreased the number of larger ACFs that have more than 3 aberrant crypts per focus. The extract inhibited the formation of O6-methylguanine and N7-methylguanine in the colonic mucosa and muscular layers but not or increased in the liver. These results indicate that M. loriformis extract has antimutagenic activity toward various known mutagens and that it inhibits AOM-induced ACF formation both in the initiation and post-initiation stages in the rat colon. (Keyword) Murdannia loriformis / antimutagenicity / azoxymethane-induced aberrant crypt foci / O6-methylguanine (Tokushima University Institutional Repository) ● Metadata: 110631 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 11901756 ● Search Scopus @ Elsevier (PMID): 11901756 (Tokushima University Institutional Repository: 110631, PubMed: 11901756)
21.	Sawitree Chiampanichayakul, Keiko Kataoka, Hideki Arimochi, Somsakul Thumvijit, Tomomi Kuwahara, Haruyuki Nakayama, Usanee Vinitketkumnuen and Yoshinari Ohnishia : Inhibitory effects of bitter melon (Momordica charantia Linn.) on bacterial mutagenesis and aberrant crypt focus formation in the rat colon, The Journal of Medical Investigation : JMI, Vol.48, No.1,2, 88-96, 2001. (Summary) Antimutagenicity and chemopreventive activity of an 80%-ethanol extract of bitter melon (Momordica charantia Linn.) against the formation of azoxymethane (AOM)-induced aberrant crypt foci (ACF) was investigated. The bitter melon extract was nonmutagenic and inhibited the mutagenicity of heterocyclic amines 2-amino-3,4-dimethylimidazo[4,5-f]quinoline and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and aflatoxin B1 in the Salmonella mutation assay. To examine the inhibitory effect of bitter melon on AOM-induced ACF formation, male F344 rats were fed various concentrations of the extract (0.1, 0.5, and 1.0 g/kg body weight) for five weeks during the initiation stage. One week after the administration of the plant extract, rats were subcutaneously given AOM at 15 mg/kg body weight once a week for two weeks. Three rats in each group were sacrificed 12 hr after the second AOM injection to analyze DNA adducts, O6-methylguanine (O6-meG) and N7-methylguanine in the liver and colon. The remaining rats were sacrificed 3 weeks after the second AOM injection to observe ACF. To examine the inhibitory effect of the extract on ACF formation in the postinitiation stage, rats were fed the extract at 0.1 and 1.0 g/kg body weight for 12 weeks starting two weeks after the second AOM injection. Treatment with bitter melon extract significantly inhibited ACF formation in the colon during the initiation stage and dose-dependently decreased the average of O6-meG DNA adduct in the colonic mucosa. During the postinitiation stage, bitter melon extract, at 1.0 g/kg body weight, significantly inhibited ACF formation in the colon, especially the formation of ACF with four or more crypts per focus. These findings suggest that bitter melon is a possible chemopreventive agent against colon carcinogenesis. (Keyword) bitter melon / Momordica charantia Linn / antimutagenicity / azoxymethane-induced aberrant crypt foci / O6-methylguanine (Tokushima University Institutional Repository) ● Metadata: 29051 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 11286022 ● Search Scopus @ Elsevier (PMID): 11286022 (Tokushima University Institutional Repository: 29051, PubMed: 11286022)
22.	Tomomi Kuwahara, Haruyuki Nakayama, Tsuyosi Miki, Keiko Kataoka, Hideki Arimochi and Yoshinari Ohnishi : PCR-dot blot hybridization based on the neuraminidase-encoding gene is useful for detection of Bacteroides fragilis, The Journal of Medical Investigation : JMI, Vol.48, No.1,2, 60-65, 2001. (Summary) Bacteroides fragilis is a Gram-negative obligate anaerobe frequently isolated from clinical specimens and sometimes causes severe septicemia in compromised hosts. Increasing interest has been shown in the enterotoxigenicity and drug resistance of B. fragilis in the field of medical microbiology. We previously reported rapid detection of this anaerobe by nested PCR targeting a neuraminidase-encoding gene nanH. In the present study, we synthesized a digoxigenin-labeled oligonucleotide probe, NH1, which is specific for nanH of B. fragilis, and we combined the hybridization assay using NH1 with the nanH-PCR to detect this anaerobe in a bacteremia model mice. In the specificity test, the oligonucleotide probe, NH1, hybridized only to amplification products from B. fragilis. PCR-dot blot hybridization based on nanH enabled detection of cells of B. fragilis in blood samples even when the number was as low as 2 x 10(3) colony-forming units/ml. These findings suggest that PCR-dot blot hybridization targeting nanH is a useful procedure for diagnosis of septicemia caused by B. fragilis when viable cells in blood cannot be detected by the traditional culture techniques. (Keyword) Bacteroides fragilis / neuraminidase / oligonucleotide probe / septicemia / PCR (Tokushima University Institutional Repository) ● Metadata: 29050 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 11286018 ● Search Scopus @ Elsevier (PMID): 11286018 (Tokushima University Institutional Repository: 29050, PubMed: 11286018)
23.	Teera Chewonarin, Tomomi Kuwahara, Hideki Arimochi, Keiko Kataoka, Haruyuki Nakayama, Dae-Yeul Yu, Hiroyuki Tsuda, Usanee Vinitketkumnuen and Yoshinari Ohnishi : Expression of Human Lactoferrin in Bacteroides uniformis and its Effect on Azoxymethane-induced Aberrant Crypt Focus Formation in the Rat Colon, Anaerobe, Vol.7, No.5, 247-253, 2001. (Keyword) lactoferrin / Bacteroides uniformis / azoxymethane / aberrant crypt foci / colon cancer (Link to Publication Site) ● Publication site (DOI): 10.1006/anae.2001.0391 (Link to Search Site for Scientific Articles) ● Summary page in Scopus @ Elsevier: 2-s2.0-0035700157 (DOI: 10.1006/anae.2001.0391, Elsevier: Scopus)
24.	Tomomi Kuwahara, Izumi Norimatsu, Haruyuki Nakayama, Shigeru Akimoto, Keiko Kataoka, Hideki Arimochi and Yoshinari Ohnishi : Genetic variation in 16S-23S rDNA internal transcribed spacer regions and the possible use of this genetic variation for molecular diagnosis of Bacteroides species, Microbiology and Immunology, Vol.45, No.3, 191-199, 2001. (Summary) The structural variation in 16S-23S rDNA internal transcribed spacer regions (ITS) among Bacteroides species was assessed by PCR amplification and sequencing analysis, and its possible use for molecular diagnosis of these species was evaluated. Ninety strains of the genus Bacteroides, including the species B. distasonis, B. eggerthii, B. fragilis, B. ovatus, B. thetaiotaomicron, B. uniformis and B. vulgatus, produced one to three ITS amplification products with sizes ranging from 615 to 810 bp. Some Bacteroides strains could be differentiated at species level on the basis of ITS amplification patterns and restriction fragment length polymorphism (RFLP) analysis using a four-nucleotide-recognizing enzyme, Msp I. The results of sequence analysis of ITS amplification products revealed genes for Ile-tRNA and Ala-tRNA in all strains tested. The nucleotide sequence, except for that in tRNA-coding regions, was highly variable and characteristic for each species, but a common sequence among B. fragilis, B. thetaiotaomicron and B. ovatus was observed. A digoxigenin-labeled oligonucleotide probe (named FOT1), which was designed from this conserved sequence, specifically hybridized to the ITS amplification products from B. fragilis, B. thetaiotaomicron and B. ovatus. These results suggest that the ITS region is a useful target for the development of rapid and accurate techniques for identification of Bacteroides species. (Keyword) Bacteroides / 16S-23S rDNA spacer / Molecular diagnosis (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 11345528 ● Summary page in Scopus @ Elsevier: 2-s2.0-0035066982 (PubMed: 11345528, Elsevier: Scopus)
25.	Hideki Arimochi, Keiko Kataoka, Tomomi Kuwahara, Haruyuki Nakayama, Norihiko Misawa and Yoshinari Ohnishi : Effects of β-Glucuronidase-Deficient and Lycopene-Producing Escherichia coli Strains on Formation of Azoxymethane-Induced Aberrant Crypt Foci in the Rat Colon, Biochemical and Biophysical Research Communications, Vol.262, No.2, 322-327, 1999.
26.	Teera Chewonarin, Takemi Kinouchi, Keiko Kataoka, Hideki Arimochi, Tomomi Kuwahara, Usanee Vinitketkumnuen and Yoshinari Ohnishi : Effects of roselle (Hibiscus sabdariffa Linn.), a Thai medicinal plant, on the mutagenicity of various known mutagens in Salmonella typhimurium and on formation of aberrant crypt foci induced by the colon carcinogens azoxymethane and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in F344 rats, Food and Chemical Toxicology, Vol.37, No.6, 591-601, 1999. (Summary) The 80% ethanol extract of roselle (Hibiscus sabdariffa Linn.), a medicinal plant in Thailand, was examined for antimutagenic and chemopreventive activity in a colon carcinogenesis model. It reduced about 60-90% of the mutagenicity induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and other heterocyclic amines 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), 2-amino-3,4-dimethylimidazo[4,5-f]quinoline(MelQ),2-amino-3, 8-dimethylimidazo[4,5-f]quinoxaline(MelQx),3-amino-1,4-dimet hyl-5H-pyrido[4,3-b]indole (Trp-P-1), 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2),2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1),2-aminodipyrido[1,2-a:3',2'-d]imidazole (Glu-P-2), at a concentration of 12.5 mg/plate in the Salmonella mutation assay. The extract showed no mutagenicity and no antibacterial activity below this dose. Mutagenicity of methylazoxymethanol (MAM) acetate, which, like PhIP, is a colon carcinogen,was also efficiently inhibited by the roselle extract. To investigate chemoprevention by roselle in a colon carcinogenesis model, we examined the inhibitory effects of the roselle extract in F344 rats in which aberrant crypt focus (ACF) formation was induced by azoxymethane (AOM) and PhIP. In the initiation stage, the number of AOM-induced ACF in the colon was significantly decreased by roselle (17-25%) compared with that in rats treated with AOM alone. The amount of O6-methylguanine in the colonic mucosa tended to be decreased in the roselle-treated rats. The number of PhIP-induced ACF was also significantly decreased by roselle treatment (22%) at a concentration of 1.0 g/kg body weight in the initiation stage. However, in the post-initiation stage of AOM-induced ACF formation, roselle increased the number of ACF, especially the number of foci which had more than three crypts/focus. These results indicate that roselle has antimutagenic activity against MAM acetate and heterocyclic amines and that it decreases the number of AOM- and PhIP-induced ACF in the initiation stage, although it rather increased the number of ACF in the post-initiation stage. (Keyword) roselle / chemoprevention / colon cancer / azoxymethane / aberrant crypt foci / heterocyclic amines / medicinal plant / antimutagenicity / PhIP / Hibiscus sabdariffa (Link to Publication Site) ● Publication site (DOI): 10.1016/S0278-6915(99)00041-1 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 10478827 ● Search Scopus @ Elsevier (PMID): 10478827 ● Search Scopus @ Elsevier (DOI): 10.1016/S0278-6915(99)00041-1 (DOI: 10.1016/S0278-6915(99)00041-1, PubMed: 10478827)
27.	Ruo Shan Bing, Takemi Kinouchi, Keiko Kataoka, Tomomi Kuwahara and Yoshinari Ohnishi : Protective effects of a culture supernatant of Lactobacillus acidophilus and antioxidants on ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug, Microbiology and Immunology, Vol.42, No.11, 745-753, 1998.
28.	Takemi Kinouchi, Keiko Kataoka, Ruo Shan Bing, Haruyuki Nakayama, Motoo Uejima, Kazuyuki Shimono, Tomomi Kuwahara, Shigeru Akimoto, Isao Hiraoka and Yoshinari Ohnishi : Culture supernatants of Lactobacillus acidophilus and Bifidobacterium adolescentis repress ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug by suppressing unbalanced growth of aerobic bacteria and lipid peroxidation, Microbiology and Immunology, Vol.42, No.5, 347-355, 1998.
29.	Hideki Arimochi, Takemi Kinouchi, Keiko Kataoka, Tomomi Kuwahara and Yoshinari Ohnishi : Activation of 1-nitropyrene by nitroreductase increases the DNA adduct level and mutagenicity, The Journal of Medical Investigation : JMI, Vol.44, No.3-4, 193-198, 1997. (Summary) 1-Nitropyrene (1-NP) is a mutagenic nitro compound in the environment. We studied correlations between the mutagenicity of 1-NP for three strains of Salmonella typhimurium, the activity of bacterial nitroreductases and the amount of 1-NP-derived DNA adducts. Bacterial strains used in this study were S. typhimurium strains TA98, nitroreductase-less mutant TA98NR and YG1021 carrying a nitroreductase-producing plasmid. The mutagenicity of 1-NP was measured using the Ames assay, and the nitroreductase activities of these strains were assayed by quantification of 1-aminopyrene produced from 1-NP. The DNA adducts were measured by the 32P-postlabeling method. Among the three bacterial strains, strain YG1021 was the highest in mutagenicity of 1-NP, the nitroreductase activity and the DNA adduct level. However, S. typhimurium strain TA98NR had the lowest values of these three parameters. Nitroreductase activity, DNA adduct level and mutagenicity were strongly correlated with each other. These results indicate that bacterial nitroreductase plays an important role in forming the DNA adducts, and that the higher the adduct level the higher the level of mutagenicity. (Keyword) Salmonella typhimurium / 1-nitropyrene / nitroreductase activity / DNA adduct / mutagenicity (Tokushima University Institutional Repository) ● Metadata: 110666 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 9597808 ● Search Scopus @ Elsevier (PMID): 9597808 (Tokushima University Institutional Repository: 110666, PubMed: 9597808)
30.	Hideki Arimochi, Takemi Kinouchi, Keiko Kataoka, Tomomi Kuwahara and Yoshinari Ohnishi : Effect of Intestinal Bacteria on Formation of Azoxymethane-Induced Aberrant Crypt Foci in the Rat Colon, Biochemical and Biophysical Research Communications, Vol.238, No.3, 753-757, 1997. (Summary) The effect of intestinal bacteria on formation of azoxymethane (AOM)-induced aberrant crypt foci (ACF) and DNA adducts in the rat colon was investigated. Male Sprague-Dawley rats were administered cultures of Lactobacillus acidophilus, Bifidobacterium adolescentis, Bacteroides fragilis, Escherichia coli and Clostridium perfringens for five weeks and given injections of AOM at 15 mg/kg body weight at the first and second weeks. The number of ACF five weeks after the start of the experiment was decreased in the rats treated with the cultures or culture supernatants of L. acidophilus and C. perfringens. The half-life of O6-methylguanine (O6-meG) in the L. acidophilus group was shorter than that in the GAM broth group. The half-life of 7-methylguanine did not differ among the groups. These results suggest that the metabolite(s) of L. acidophilus and C. perfringens inhibit(s) the ACF formation in rats treated with AOM and that the inhibitory effect of L. acidophilus is due to the enhanced removal of O6-meG from the colon mucosal DNA. (Keyword) Animals / Azoxymethane / Bacteroides fragilis / Bifidobacterium / Body Weight / Clostridium perfringens / Colonic Neoplasms / Culture Media / Drinking / Escherichia coli / Guanine / Injections, Subcutaneous / Intestinal Mucosa / Lactobacillus acidophilus / Male / Rats / Rats, Sprague-Dawley (Link to Publication Site) ● Publication site (DOI): 10.1006/bbrc.1997.7384 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 9325162 ● Search Scopus @ Elsevier (PMID): 9325162 ● Search Scopus @ Elsevier (DOI): 10.1006/bbrc.1997.7384 (DOI: 10.1006/bbrc.1997.7384, PubMed: 9325162)
31.	Haruyuki Nakayama, Takemi Kinouchi, Keiko Kataoka, Shigeru Akimoto, Yoshiko Matsuda and Yoshinari Ohnishi : Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil., Pharmacogenetics, Vol.7, No.1, 35-43, 1997. (Summary) Sorivudine, 1-beta-D-arabinofuranosyl-5-(E)-(2-bromovinyl)uracil, is a potent antiviral agent against varicella-zoster virus and herpes simplex virus type 1. However, sorivudine should not be used in combination with anticancer drugs such as 5-fluorouracil (5-FU) because (E)-5-(2-bromovinyl)uracil (BVU), a metabolite of sorivudine, inhibits the degradation of 5-FU, resulting in its accumulation in the blood and marked enhancement of the toxicity of 5-FU. Since phosphorolytic enzymes generate BVU from sorivudine, we investigated the distribution of the enzyme activity in rats. High activity was found in the cecal and large intestinal contents, while very low or no detectable activity in the liver, kidney, stomach, cecum, large intestine, and the stomach and small intestinal contents. These results suggest that intestinal microflora play an important role in BVU production. Therefore, we measured the phosphorylase activity in cell-free extracts from 23 aerobes, 16 anaerobes and a fungus. Bacteroides species B. vulgatus, B. thetaiotaomicron, B. fragilis, B. uniformis and B. eggerthii, dominant members of intestinal microflora, had high activity to convert sorivudine to BVU. To elucidate the contribution of intestinal microflora to BVU production in vivo, we administered sorivudine to rats treated with several antibiotics and measured the BVU concentration in the serum of rats. When sorivudine was given to rats treated with ampicillin or a mixture of bacitracin, neomycin and streptomycin, which decreased the numbers of viable aerobes and anaerobes, only a small amount of BVU was found in the serum. BVU concentration in the serum of rats treated with metronidazole to decrease the number of intestinal anaerobes was also very low. In contrast, BVU concentration in the serum of rats treated with kanamycin, which was used to decrease the number of aerobes selectively, was higher than that of non-treated rats. These results also suggest that BVU is produced by intestinal anaerobic bacteria especially Bacteroides species in vivo. (Keyword) Animals / Antiviral Agents / Arabinofuranosyluracil / Bacteria, Anaerobic / Bacteroides / Biotransformation / Bromouracil / Cecum / Fluorouracil / Gastric Mucosa / Gastrointestinal Contents / Intestinal Mucosa / Kidney / Liver / Male / Organ Specificity / Pentosyltransferases / Pyrimidine Phosphorylases / Rats / Rats, Sprague-Dawley (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 9110360 ● CiNii @ National Institute of Informatics (CRID): 1570854175671010176 ● Search Scopus @ Elsevier (PMID): 9110360 (PubMed: 9110360, CiNii: 1570854175671010176)

Academic Paper (Unrefereed Paper):

1.	Yoshinari Ohnishi, Keiko Kataoka, Hideki Arimochi, Tomomi Kuwahara, Haruyuki Nakayama and 萩原真理 : 腸内菌の機能, 日本臨床腸内微生物学会誌, Vol.6, No.1, 5-9, 2004. (Keyword) 腸内菌 / 非ステロイド性抗炎症薬 / 異常腺窩巣 / lycopene / プロバイオティクス

Review, Commentary:

1.	Keiko Kataoka : The intestinal microbiota and its role in human health and disease, The Journal of Medical Investigation : JMI, Vol.63, No.1,2, 27-37, Feb. 2016. (Summary) The role of the intestinal microbiota in human health is gaining more attention since clear changes in the composition of the intestinal bacteria or environment are seen in patients with inflammatory bowel disease, allergy, autoimmune disease, and some lifestyle-related illnesses. A healthy gut environment is regulated by the exquisite balance of intestinal microbiota, metabolites, and the host's immune system. Imbalance of these factors in genetically susceptible persons may promote a disease state. Manipulation of the intestinal microbiota with prebiotics, which can selectively stimulate growth of beneficial bacteria, might help to maintain a healthy intestinal environment or improve diseased one. In this review, analytical methods for identification of intestinal bacteria and an update on the correlation of the intestinal microbiota with human health and disease were discussed by introducing our recent studies to determine the prebiotic effects of a fiber-rich food in animal model and on healthy people and patients with ulcerative colitis (UC). (Tokushima University Institutional Repository) ● Metadata: 111149 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.63.27 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27040049 ● Summary page in Scopus @ Elsevier: 2-s2.0-84962200721 (Tokushima University Institutional Repository: 111149, DOI: 10.2152/jmi.63.27, PubMed: 27040049, Elsevier: Scopus)
2.	Keiko Kataoka : Intestinal microbiota and its role in human health, Shikoku Acta Medica, Vol.70, No.5,6, 139-148, Dec. 2014. (Summary) The healthy gut environment is complicated and controlled by the balance of intestinal immune system, intestinal microbiota, and microbial metabolites produced by intestinal bacteria. Imbalance of these elements in genetically susceptible persons has been known to promote inflammatory bowel disease and some lifestyle-related illnesses. Manipulation of intestinal microbiota with prebiotics, which can selectively stimulate a growth of beneficial bacteria, might contribute to keep healthy condition and to improve patient's condition. I present some results of prebiotic effects in animal model and placebo-controlled, crossover study in healthy adults and patients with ulcerative colitis (UC). Through the clinical study, we found that UC patients had differences in microbiota composition and microbial metabolites. Decrease of Dominant anaerobic bacteria Bacteroides and diversity of microbiota composition was observed in UC. Amount of organic acids produced by bacterial fermentation reflectively decreased. Update on correlation of intestinal bacteria with human health and disease are reviewed. (Keyword) intestinal microbiota / ulcerative colitis / prebiotics / Bacteroides / organic acid (Tokushima University Institutional Repository) ● Metadata: 109893 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050865122807682304 (Tokushima University Institutional Repository: 109893, CiNii: 1050865122807682304)
3.	Hideki Arimochi, Takemi Kinouchi, Keiko Kataoka, Tomomi Kuwahara and Yoshinari Ohnishi : 大腸前癌病変発生に対する腸内菌の影響, Journal of Japanese Society for Gastroenterological Carcinogenesis, Vol.10, 29-30, 1998.

Proceeding of International Conference:

1.	Keiko Kataoka : Fermented brown rice and rice bran delayed onset of spontaneous type 1 diabetes in NOD mice, International Conference on Food Technology & Nutrition, Dec. 2021.
2.	Keiko Kataoka : Suppressive effect of fermented brown rice and rice bran on spontaneous type 1 diabetes in NOD mice, 7th International Conference on Food Chemistry and Technology, Online, Nov. 2021.
3.	Misato Moriki, Akiko Sakurai and Keiko Kataoka : High-fat high-sucrose diet induced fatty liver disease and gut microbiota in obese mice., Technological Competency as Caring in the Health Sciences (2018), Aug. 2018. (Keyword) gut microbiota / culture-independent analysis / obecity / non-alcoholic fatty liver disease / high-fat high-sucrose diet
4.	Yoshinari Ohnishi, Keiko Kataoka, Hideki Arimochi, Shuusuke Nakanishi, Piyawan Bunpo, Naruhiko Sawada, Haruyuki Nakayama, Tomomi Kuwahara and Usanee Vinitketkumnuen : PREVENTION OF COLORECTAL CARCINOGENESIS IN RATS, The 3rd International Congres of Asian Society of Toxicology, Bangkok, Feb. 2004.
5.	Hideki Arimochi, Teera Chewonarin, Keiko Kataoka, Tomomi Kuwahara, Haruyuki Nakayama, Yeul-Dae Yu, Hiroyuki Tsuda, Usanee Vinitketkumnuen and Yoshinari Ohnishi : Effects of cultures of β-glucuronidase-deficient Escherichia coli and lactoferrin-producing Bacteroides uniforinis on formation of azoxymethane-Induced aberrant crypt foci in the rat colon, ICIB2001, Tokyo, Jul. 2001.
6.	Hideki Arimochi, Teera Chewonarin, Keiko Kataoka, Tomomi Kuwahara, Haruyuki Nakayama, Norihiko Misawa, Hiroyuki Tsuda, Dae-Yeul Yu, Usanee Vinitketkumnuen and Yoshinari Ohnishi : Prevention of colon carcinogen-induced aberrant crypt focus formation by functional intestinal bacteria., Takeo Wada Cancer Research Symposium, Chiang Mai, Nov. 2000.
7.	Hideki Arimochi, Keiko Kataoka, Tomomi Kuwahara and Yoshinari Ohnishi : Effect of Intestinal bacteria and lycopene-producing Escherichia coli on the formation of preneoplastic colonic lesions induced by azoxymethana in rat, AACR Annual Meeting, Philadelphia, Apr. 1999.
8.	Yoshinari Ohnishi, Keiko Kataoka, Takemi Kinouchi, Hideki Arimochi, Tomomi Kuwahara, Teera Chewonarin, Yaowarate Intiyot and Usanee Vinitketkumnuen : EFFECTS OF MEDICINAL PLANTS AND ANTIBIOTICS ON FORMATION OF 2-AMINO-1-METHYL-6-PHENYLIMIDAZO(4,5-b) PYRIDINE(PhIP)-INDUCED ABERRANT CRYPT FOCI IN THE RAT COLON., The 7th International Conference on Carcinogenic/Mutagenic N-Substituted Aryl Compounds First Circular, Nagoya, Nov. 1998.
9.	Tomomi Kuwahara, Shigeru Akimoto, Izumi Norimatsu, Syed Mohammed Shaheduzzaman, Haruyuki Nakayama, Hideki Arimochi, Keiko Kataoka and Yoshinari Ohnishi : DNA diagnosis of the genus Bacteroides and related species., 第4回日韓国際微生物学シンポジウム, Tokushima, Oct. 1998.
10.	Yoshinari Ohnishi, Keiko Kataoka, Takemi Kinouchi, Hideki Arimochi, R Yoshida, Tomomi Kuwahara, Ratchads Suaeyun, Teera Chewonarin, Yaowarate Intiyot and Usanee Vinitketkumnuen : Inhibitory effects of medicinal plants and their components on bacterial mutagenesis and the initiation stage of colon carcinogenesis, 17th International Cancer Congress, Rio de Janeiro, Aug. 1998.
11.	Takemi Kinouchi, Ratchada Suaeyun, Teera Chewonarin, Yaowarate Intiyot, Hideki Arimochi, Keiko Kataoka, Shigeru Akimoto, Usanee Vinitketkumnuen and Yoshinari Ohnishi : CHEMOPREVENTIVE EFFECTS OF THAI MEDICINAL PLANTS ON FPRMATION OF AZOXYMETHANE-INDUCED DNA ADDUCTS AND ABERRANT CRYPT FOCI IN THE RAT COLON, 7th Iat Can Env Mutagenesi, Zuerich, Sep. 1997.

Proceeding of Domestic Conference:

1.	ISHIKAWA Ryuji, OHNISHI Hikari, Mayuko Shimizu, Akiko Sakurai and Keiko Kataoka : 幼若期のアンピシリン暴露が食餌誘導性NASHモデルマウスに及ぼす影響, 第97回日本細菌学会総会, Aug. 2024.
2.	YONEMOTO Haruka, Tatsuya Tominaga, Akiko Sakurai and Keiko Kataoka : 細菌由来細胞外小胞(エクソソーム)放出量の検討, 第47回徳島県医学検査学会, Dec. 2023.
3.	MANABE Hirai, OHNISHI Hikari, YASUTOMI Hiroto, ISHIKAWA Ryuji, FUKUNAGA Satoko, Keiko Kataoka and Akiko Sakurai : 幼若期の抗菌薬暴露が食餌誘導性NASHモデルマウスの腸内細菌叢に及ぼす影響, 第47回徳島県医学検査学会, Dec. 2023.
4.	OHNISHI Hikari, MANABE Hirai, YASUTOMI Hiroto, ISHIKAWA Ryuji, FUKUNAGA Satoko, Keiko Kataoka and Akiko Sakurai : 高脂肪特殊飼料摂取マウスにおける非アルコール性脂肪肝炎(NASH)と幼若期抗菌薬投与の影響, 第47回徳島県医学検査学会, Dec. 2023.
5.	ISHIKAWA Ryuji and Keiko Kataoka : 食餌誘導性NASHモデルマウスにおける幼若期のアンピシリン投与の影響について, 第76回日本細菌学会中国・四国支部総会(松山大学), Oct. 2023.
6.	Sayuko Kagawa, ISHIKAWA Ryuji, Toshiyuki Yasui, Akiko Sakurai and Keiko Kataoka : 出生後の児の便中細菌叢および有機酸濃度の経時的変化と影響要因, 第96回日本細菌学会総会, Mar. 2023.
7.	Miku Shimomura, Himari Usuki, Sayuko Kagawa, ISHIKAWA Ryuji, Akiko Sakurai and Keiko Kataoka : 食餌誘導性NASHモデルマウスの腸内細菌叢の16Sメタゲノム解析の試み, 第46回徳島県医学検査学会, Dec. 2022.
8.	Sayuko Kagawa, Miku Shimomura, Himari Usuki, Toshiyuki Yasui, Akiko Sakurai and Keiko Kataoka : ヒトの腸内細菌叢の形成過程における腸内環境の変化, 第46回徳島県医学検査学会, Dec. 2022.
9.	Himari Usuki, Miku Shimomura, Sayuko Kagawa, Akiko Sakurai and Keiko Kataoka : 高脂肪特殊飼料摂取におけるNASHモデルマウス肝臓組織の線維化・炎症関連遺伝子発現レベルの検討, 第46回徳島県医学検査学会, Dec. 2022.
10.	松田修己, 東野乃, 田中莉乃, Akiko Sakurai and Keiko Kataoka : NASHモデルマウスにおける幼若期の抗菌薬暴露が腸内環境に及ぼす影響, 第95回日本細菌学会総会, Mar. 2022.
11.	SATOH Tomomi, Yuka Hiroshima, Akikazu Murakami, Hideki Fujii, Akiko Sakurai, Keiko Kataoka and Keiji Murakami : カタラーゼをコードするkatA/katB遺伝子が及ぼす緑膿菌の抗菌薬抵抗性における影響, 第45回徳島県医学検査学会, Dec. 2021.
12.	Rino Tanaka, Yoshimi Matsuda, Toshiyuki Yasui, Akiko Sakurai and Keiko Kataoka : ヒトの腸内細菌叢の形成過程における菌叢構成および便中有機酸濃度の変化について, 第45回徳島県医学検査学会, Dec. 2021.
13.	Yoshimi Matsuda, Rino Tanaka, Nono Higashi, Akiko Sakurai and Keiko Kataoka : NASHモデルマウスにおける離乳までの時期の抗菌薬曝露が腸内環境に及ぼす影響, 第45回徳島県医学検査学会, Dec. 2021.
14.	Nono Higashi, Rino Tanaka, Yoshimi Matsuda, Akiko Sakurai and Keiko Kataoka : 高脂肪特殊飼料摂取におけるNASHモデルマウス肝臓組織の線維化の検討, 第45回徳島県医学検査学会, Dec. 2021.
15.	Nozomi Fujimoto, Miyu Higasa, Akiko Sakurai and Keiko Kataoka : 非アルコール性脂肪肝炎モデルマウスにおける幼若期の抗菌薬暴露の影響, 第94回日本細菌学会総会, Mar. 2021.
16.	Makoto Ogasa, Akiko Sakurai, Keiko Kataoka, 越智ありさ and Hideharu Abe : ヒト尿沈渣中のCXC Chemokine Receptor遺伝子発現について, 第44回徳島県医学検査学会, Dec. 2020.
17.	Rina Murata, Keiji Murakami, Yuka Hiroshima, Koichiro Tsuchiya, Keiko Kataoka and Hideki Fujii : 緑膿菌における抗菌薬添加によるスーパーオキシドの発生について, 第73回日本細菌学中国・四国支部総会, 22, Oct. 2020.
18.	Keiji Murakami, 村田梨菜, Koichiro Tsuchiya, Keiko Kataoka and Hideki Fujii : 緑膿菌における抗菌薬添加による酸化ストレスについて, 第54回緑膿菌感染症研究会, Feb. 2020.
19.	村田梨菜, Keiji Murakami, Yuka Hiroshima, Keiko Kataoka and Hideki Fujii : 緑膿菌における抗菌薬添加による酸化ストレス反応について, 第93回日本細菌学会総会, Feb. 2020.
20.	岡本舞, Yuta Kita, Rina Murata, Pahlevi Reza Muhammad, Keiji Murakami, Yuka Hiroshima, Keiko Kataoka and Hideki Fujii : 緑膿菌におけるバイオフィルム形成菌の抗菌薬抵抗性について, 徳島県歯科医学大会, Feb. 2020.
21.	Rina Murata, Pahlevi Reza Muhammad, Keiji Murakami, Yuka Hiroshima, Keiko Kataoka and Hideki Fujii : 緑膿菌における抗菌薬添加と酸化ストレスについて, 徳島県歯科医学大会, Feb. 2020.
22.	Keisuke Teramoto, Nozomi Fujimoto, Rina Murata, Akiko Sakurai and Keiko Kataoka : 高脂肪高ショ糖食の摂取によるマウスの腸内細菌叢の変化とマウス週齢との関連について, 第43回徳島県医学検査学会, Dec. 2019.
23.	Rio Tanaka, Miho Tamaki, Keisuke Teramoto, Nozomi Fujimoto, Toshiyuki Yasui, Akiko Sakurai and Keiko Kataoka : 乳児の腸内細菌叢におけるBifidobacterium属の変動と分娩様式の違いとの関連について, 第43回徳島県医学検査学会, Dec. 2019.
24.	Miho Tamaki, Rio Tanaka, Keisuke Teramoto, Nozomi Fujimoto, Toshiyuki Yasui, Akiko Sakurai and Keiko Kataoka : 出生後1年までの乳児の腸内細菌叢の変化と環境要因の関連について, 第43回徳島県医学検査学会, Dec. 2019.
25.	Eishi Higuchi, Nozomi Fujimoto, Rina Murata, Akiko Sakurai and Keiko Kataoka : 2型糖尿病モデルマウスに対する玄米発酵食品の発症抑制効果-膵臓組織でのインスリンと関連タンパク質の発現量の比較-, 第43回徳島県医学検査学会, Dec. 2019.
26.	Nozomi Fujimoto and Keiko Kataoka : 分娩様式と栄養方法が出生後の児の腸内菌叢に及ぼす影響, 第72回日本細菌学会中国・四国支部総会, Nov. 2019.
27.	藤本望, 村田梨菜, Keiji Murakami, Yuka Hiroshima, Keiko Kataoka and Hideki Fujii : 亜硝酸イオンの口腔内における生理的意義について, 第72回日本細菌学会中国・四国支部総会, Nov. 2019.
28.	村田梨菜, 藤本望, Keiji Murakami, Yuka Hiroshima, Keiko Kataoka and Hideki Fujii : 緑膿菌における抗菌薬添加と酸化ストレスについて, 第72回日本細菌学会中国・四国支部総会, Nov. 2019.
29.	Keiji Murakami, 喜田悠太, 村田梨菜, Yuka Hiroshima, Keiko Kataoka and Hideki Fujii : 緑膿菌バイオフィルム形成菌の抗菌薬抵抗性に関わる遺伝子について, 第33回日本バイオフィルム学会学術集会, Jul. 2019.
30.	Keiji Murakami, 天羽崇, Keiko Kataoka and Hideki Fujii : The correlation between antibiotic tolerance and antioxidant ability in Pseudomonas aeruginosa, The 92nd Annual Meeting of Japanese Society for Bacteriology, Apr. 2019.
31.	Keiko Kataoka, Misato Moriki, Akiko Sakurai, Haruyuki Imaohji and Tomomi Kuwahara : Feeding style of high fat high sucrose diet affects gut environment and nonalcoholic fatty liver disease in mice., The 92nd Annual Meeting of Japanese Society for Bacteriology, Apr. 2019.
32.	Shimpei Morino, Misato Moriki, Akiko Sakurai and Keiko Kataoka : 1型糖尿病に対する玄米発酵食品の発症抑制効果∼モデルマウスにおける膵臓細胞のアポトーシス抑制とインスリン発現レベルの検討∼, 第42回徳島県医学検査学会, Dec. 2018.
33.	Rina Murata, Keiji Murakami, Hideki Fujii, 佐藤雅美, 笹田倫子, 井上みなみ, 平尾早紀, 別所将弘, Momoyo Azuma, Akiko Sakurai and Keiko Kataoka : 呼吸器感染症患者由来緑膿菌の抗菌薬抵抗性と抗酸化能の関連について, 第42回徳島県医学検査学会, Dec. 2018.
34.	Shiho Takemasa, Minami Urushihara, Misato Moriki, Toshiyuki Yasui, Akiko Sakurai and Keiko Kataoka : 分娩様式と栄養方法が出生後の腸内菌叢に及ぼす影響について, 第42回徳島県医学検査学会, Dec. 2018.
35.	Minami Urushihara, Shiho Takemasa, Misato Moriki, Toshiyuki Yasui, Akiko Sakurai and Keiko Kataoka : 分娩様式と栄養方法が出生後の腸内環境に及ぼす影響について, 第42回徳島県医学検査学会, Dec. 2018.
36.	Misato Moriki, Yuri Morimoto, Akiko Sakurai and Keiko Kataoka : The timing of high-fat high-sucrose diet intake affects gut microbiota and fatty liver disease in mice., 第22回腸内細菌学会, May 2018. (Keyword) gut microbiota / high-fat high-sucrose diet / fatty liver disease
37.	Keiji Murakami, Takashi Amoh, Keiko Kataoka, 狩山玲子, Katsuhiko Hirota, Yoichiro Miyake and Hideki Fujii : 緑膿菌オートインデューサーアナログのマクロライドに対する効果, 第91回日本細菌学会総会, Mar. 2018.
38.	Narumi Senoh, Chiaki Matsuda, Yuri Morimoto, Misato Moriki, Akiko Sakurai and Keiko Kataoka : 高脂肪高ショ糖食摂取マウスの脂肪組織および肝臓細胞での遺伝子発現に対する玄米発酵食品の影響, 第41回徳島県医学検査学会, Dec. 2017.
39.	Ryo Kuge, Chiaki Matsuda, Yuri Morimoto, Misato Moriki, Akiko Sakurai and Keiko Kataoka : 2型糖尿病モデルマウスに対する玄米発酵食品摂取の効果-免疫組織染色を用いた膵臓PDX-1発現分布の検討-, 第41回徳島県医学検査学会, Dec. 2017.
40.	Chiaki Matsuda, Yuri Morimoto, Misato Moriki, Akiko Sakurai and Keiko Kataoka : 1型糖尿病にたいする玄米発酵食品の発症抑制効果-モデルマウスにおける膵臓遺伝子発現レベルの検討-, 第41回徳島県医学検査学会, Dec. 2017.
41.	Keiji Murakami, Takashi Amoh, Katsuhiko Hirota, Keiko Kataoka and Yoichiro Miyake : 緑膿菌呼吸器感染症における抗菌薬抵抗性の臨床的重要性について「シンポジウム不均一性細菌学:表現型の不均一性に基づいた細菌の生存戦略」, 第90回日本細菌学会総会, Mar. 2017.
42.	Shoto Ogawa, Shinichi Fujie, Keiji Murakami, Takashi Amoh, Yoichiro Miyake, 佐藤雅美, 笹田倫子, 菅崎幹樹, 香川葉子, Yuri Morimoto, Momoyo Azuma, Akiko Sakurai and Keiko Kataoka : 緑膿菌オートインデューサー類似化合物が抗菌薬抵抗性に及ぼす影響, 第40回徳島県医学検査学会, Dec. 2016.
43.	Mayuko Gohji, Keiko Komatsu, Yuri Morimoto, Akiko Sakurai and Keiko Kataoka : 1型糖尿病に対する玄米発酵食品の発症抑制効果-モデルマウスにおける膵臓PDX-1発現レベルの検討-, 第40回徳島県医学検査学会, Dec. 2016.
44.	Keiko Komatsu, Mayuko Gohji, Yuri Morimoto, Keiko Kataoka and Akiko Sakurai : 高脂肪高ショ糖食摂取マウスの血中レジスチン濃度に対する玄米発酵食品の影響, 第40回徳島県医学検査学会, Dec. 2016.
45.	Yuri Morimoto, Akiko Sakurai and Keiko Kataoka : 高脂肪食により誘導される生活習慣病のリスクに対する玄米発酵食品の影響, 第11回日本臨床検査学教育学会学術大会, Sep. 2016.
46.	Yuri Morimoto and Keiko Kataoka : 高脂肪高ショ糖食投与マウスの糞便菌叢に対する玄米発酵食品の影響, 第89回日本細菌学会総会, Mar. 2016.
47.	Tatsuya Shirai, Yuri Morimoto, Akiko Sakurai and Keiko Kataoka : 食事誘導性肥満マウスの腸内菌叢に対する玄米発酵食品投与の影響, 第39回徳島県医学検査学会, Dec. 2015.
48.	Ayumi Yoshida, Mai Ueta, Keiji Murakami, Yoichiro Miyake, 佐藤雅美, 笹田倫子, 菅崎幹樹, 香川葉子, Yuri Morimoto, Momoyo Azuma, Akiko Sakurai and Keiko Kataoka : 緑膿菌におけるストレス応答と抗菌薬抵抗性について, 第39回徳島県医学検査学会, Dec. 2015.
49.	Mai Ueta, Ayumi Yoshida, Keiji Murakami, Yoichiro Miyake, 佐藤雅美, 笹田倫子, 菅崎幹樹, 香川葉子, Yuri Morimoto, Momoyo Azuma, Akiko Sakurai and Keiko Kataoka : リボザイムを応用したcyclic-di-GMPの定量法の開発, 第39回徳島県医学検査学会, Dec. 2015.
50.	Keiji Murakami, Hideaki Maseda, 天羽崇, Katsuhiko Hirota, Keiko Kataoka and Yoichiro Miyake : 臨床および環境分離緑膿菌の抗菌薬抵抗性と病原因子に関する検討, 第88回日本細菌学会総会, Mar. 2015.
51.	Yukari Yoshikawa, Shoko Kannuki, Keiji Murakami, Yoichiro Miyake, 畑美智子, 佐藤雅美, 笹田倫子, 香川葉子, 菅崎幹樹, Momoyo Azuma, Akiko Sakurai and Keiko Kataoka : 本院で分離されたST-8型MRSAについて, 第38回徳島県医学検査学会, Dec. 2014.
52.	Shoko Kannuki, Yukari Yoshikawa, Keiji Murakami, Yoichiro Miyake, Hideaki Maseda, 畑美智子, 佐藤雅美, 笹田倫子, 香川葉子, 菅崎幹樹, Momoyo Azuma, Akiko Sakurai and Keiko Kataoka : 臨床および環境分離緑膿菌における病原性について, 第38回徳島県医学検査学会, Dec. 2014.
53.	Chihiro Itami, Akiko Sakurai and Keiko Kataoka : 高脂肪高ショ糖食がマウス腸内菌叢に及ぼす影響について, Dec. 2014.
54.	Keiko Kataoka : Notchシグナルは小腸粘膜固有層に存在するCD4+CD11c+細胞の分化に必要である, 第40回日本免疫学会学術集会, Nov. 2011.

Et cetera, Workshop:

1.	Masaki SATOH, Maki Nakamura, Noa Ichikawa, ISHIKAWA Ryuji, Satoko FUKUNAGA, Yuko Narusawa, Michiko Yamashita, Keiko Kataoka and Akiko Sakurai : NASH model mouse, THE TOKUSHIMA JOURNAL OF MEDICAL TECHNOLOGY, 22, Dec. 2024.
2.	Miyu Higasa, Yuma Takemoto, Nozomi Fujimoto, Rina Murata, Akiko Sakurai and Keiko Kataoka : NASHモデルマウスにおける離乳までの時期の抗菌薬暴露の影響について, 第44回徳島県医学検査学会, Dec. 2020.
3.	Saho Yamanaka, Rina Murata, Keiji Murakami, Yuka Hiroshima, Hideki Fujii, Akiko Sakurai and Keiko Kataoka : 緑膿菌の抗菌薬抵抗性に関与する二成分制御系について, 第44回徳島県医学検査学会, Dec. 2020.
4.	Yuma Takemoto, Miyu Higasa, Nozomi Fujimoto, Toshiyuki Yasui, Akiko Sakurai and Keiko Kataoka : 乳児の腸内細菌叢における Bifidobacterium 属の変動について, 第44回徳島県医学検査学会, Dec. 2020.
5.	Rina Murata, Keiji Murakami, Yuka Hiroshima, Koichiro Tsuchiya, Keiko Kataoka and Hideki Fujii : 緑膿菌における抗菌薬添加によるスーパーオキシドの発生について, 徳島大学研究クラスター Joint Meeting on Microbiology 2020, Nov. 2020.
6.	Keiji Murakami, 村田梨菜, Takashi Amoh, Keiko Kataoka and Hideki Fujii : 緑膿菌臨床分離株における抗菌薬抵抗性と抗酸化能との関連について, 第53回緑膿菌感染症研究会プログラム, Mar. 2019.
7.	Keiko Kataoka : 非アルコール性脂肪肝炎に対するFBRAの抑制効果の検討, 第39回徳FBRA学術研究会, Sep. 2018.
8.	Keiko Kataoka : 糖尿病モデルマウスにおけるFBRA投与の効果について, 第38回FBRA学術研究会, Mar. 2018.
9.	Mizuki Abe, Narumi Senoh, Keiji Murakami, Takashi Amoh, Hideki Fujii, 佐藤雅美, 笹田倫子, 菅崎幹樹, 森本悠里, 平尾早紀, Akiko Sakurai and Keiko Kataoka : オートインデューサーアナログ(AIA)の緑膿菌に及ぼす影響, 第41回徳島県医学検査学会, Dec. 2017.
10.	Keiko Kataoka : 2型糖尿病モデルにおけるFBRA投与の効果について, 第37回FBRA学術研究会, Sep. 2017.
11.	Keiko Kataoka : 糖尿病モデルマウスにおけるFBRAの発症抑制効果, 第36回FBRA学術研究会, Feb. 2017.
12.	Shinichi Fujie, Shoto Ogawa, Keiji Murakami, Takashi Amoh, Yoichiro Miyake, 佐藤雅美, 笹田倫子, 菅崎幹樹, 香川葉子, Yuri Morimoto, Momoyo Azuma, Akiko Sakurai and Keiko Kataoka : 呼吸器由来緑膿菌における病原性と抗菌薬抵抗性との関連について, 第40回徳島県医学検査学会, Dec. 2016.
13.	Keiko Kataoka : 糖尿病モデルマウスにおけるFBRAの発症抑制効果, 第35回FBRA学術研究会, Aug. 2016.
14.	Keiko Kataoka : 糖尿病モデルマウスにおけるFBRAの発症抑制効果, 第34回FBRA学術研究会, Feb. 2016.
15.	Keiko Kataoka : 糖尿病モデルマウスにおけるFBRAの発症抑制効果, 第33回FBRA研究会, Aug. 2015.
16.	Keiko Kataoka : 糖尿病モデルマウスにおけるFBRAの発症抑制効果, 第32回FBRA研究会, Feb. 2015.
17.	Keiko Kataoka and 林晴香 : 2型糖尿病モデルマウスにおける発酵食品の発症抑制作用について, 徳島県医学検査学会, Dec. 2013.
18.	Keiko Kataoka, 南亜利沙, Keiji Murakami, Yoichiro Miyake, 畑美智子, 佐藤雅美, 岡本貴子, 香川葉子, 菅崎幹樹 and Momoyo Azuma : 本院で分離されたMRSAの分類とその特徴, 徳島県医学検査学会, Dec. 2013.
19.	Keiko Kataoka, 堀口なつみ, Keiji Murakami, Yoichiro Miyake, 畑美智子, 佐藤雅美, 岡本貴子, 香川葉子, 菅崎幹樹 and Momoyo Azuma : 「緑膿菌臨床分離株における抗菌薬抵抗性について」, 徳島県医学検査学会, Dec. 2013.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

Stability of gut microbiota and its relationship with a risk of nonalcoholic fatty liver disease. (Project/Area Number: 22K11725 )
Intervention to gut microbiota and reduction of the risk of non-alcoholic steatohepatitis. (Project/Area Number: 19K11719 )
The timing of high-fat high-sucrose diet intake affects gut microbiota and fatty liver disease in mice (Project/Area Number: 15K00820 )
Importance of intestinal bacteria and dietary habits to maintain human health (Project/Area Number: 23500958 )
Effects of deviated food habit on autoimmune and allergic diseases, and their association with intestinal microflora (Project/Area Number: 23500957 )
Influence of dietary habits on gut health and occurrence of allergic diseases (Project/Area Number: 20500709 )
Analysis of infectious factors of Bacteroides fragilis in the compromised host (Project/Area Number: 15590389 )
生理活性物質産生腸内フローラによる疾病の予防と治療 (Project/Area Number: 12877047 )
植物成分および機能性腸内菌による大腸発がんの防御機構の研究 (Project/Area Number: 12213093 )
Mechanisms of inhibition of drug-induced ulcer formation by intestinal bacteria (Project/Area Number: 11670265 )
発がん予防における腸内フローラの役割の解明と機能的腸内菌の開発 (Project/Area Number: 11138238 )
発がんとがん予防における腸内フローラの役割の解明と機能的腸内菌の開発 (Project/Area Number: 10151235 )
HUS development associated with bacterial infection and prevention against HUS (Project/Area Number: 09670284 )
発がんとがん予防における腸内フローラの役割の解明と機能的腸内菌の開発 (Project/Area Number: 09253240 )
Role of intestinal bacteria in small intestinal ulcer formation and prevention in rats treated with a nonsteroidal antiinflammatory drug. (Project/Area Number: 06670296 )
Search by Researcher Number (40189303)

Professor : Kataoka, Keiko

Research

Personal Web Page

Field of Study

Subject of Study

Book / Paper

Book:

Academic Paper (Judged Full Paper):

Academic Paper (Unrefereed Paper):

Review, Commentary:

Proceeding of International Conference:

Proceeding of Domestic Conference:

Et cetera, Workshop:

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)